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Analysis of cancer-associated colonic mucin by ion-exchange 
chromatography: evidence for a mucin species of lower molecular 
charge and weight in cancer 
C h i k a o  S l f imamoto ,  G a y a t r i  D. D e s h m u k h ,  Wes ley  L. R igo r  a n d  C.  R i c h a r d  B o l a n d  
Depm2m~t ~ M ~  VA Medw.al Ce~, ,  a~d Um~t ,~  of Mickiga~ Sdmol of Medi~r~ A m  ~rb~. Mi IU~L.t 
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Cancer-assodated mm~s  in the colon are ~ distinct and glycosylated differemly f ~  t ha t  h o u r i  
countet'pm~ Mudn-dch glycoconjugate I~eparatiem were made from nine aoa-neel~stie coleus, serum mira  ~ 
and tlm different xenografls from mue~l f fodmi~  Immsn c ~ m  ¢an~" exll l im~ and rmliolabeled with 31-L The 
prepm'alio,~ was applled Io a DF_AE-edlMose ian-exchasge cabsm|, aml eluled with a discomkmms m~mling NaCI 
Wnal~]ent n:sm'6ag in sexea dim'ere fraefiems ex 'speeiex: Over kalf of the 3 ~  gly¢oc,~ " ~ , ~  frem spe¢~ms  
of n o a - n e o p ~  o0donic e ~ l l ~ l i m  elated in f ~  V (elated ~ 0.,25 NaCI). Sigalr~amly less of the 3 H ~  
81ycoconjagates from spechneas of celon cancer deted in fr~-t;on V ( 3 , ~  P < 0.1M05}. and dmre weme ~gnirEnet 
increases in g~yee~:u~eipdes eieded kt  f n t c ~ n s  IV ( P < ~ 8 k  m ( P < ~ . ~ S ) ~  an~ ~ ( P < ~.~28). A d d f g ~  sa~e~p~es 
were pt'epmed witlmm the ~ lWocedm'es, d~malegraphed en a DEAF.-cdtdese ~ colusm, aml 
analyzed for mmmsacekmide eantea4. Each of tlie fntc~inas m m a i l d  die moaosaecharides expee~ed in ma~m4~e 
glyco~roteins, but oaly sialk acid was d i f f e r m ~  expcessed in the sevea fractions or *species', ~ ~ in 
the mere charged spedes. Heweser, differe~es in s/allc add cemem were net smqkdem m exl~da ~ e  d i f f ~  in 
reteatien ea fire ioe-exdmage celuma, am" ~.re diffeveaces ia O-a~4a t i ea  of ~ e  macim. M u ~ t ~ p e  glymmaja~atm 
from colon caacem me relatively less ¢l~arged tlum these from the aormal coloa, aml elate at ~ m ~ ~ 
interest, cencer-asso~ated macins ml~pem- to be ~ lower mdeeulm- welght than theh- nemud conmmqpm-~ Add~o~ l  
stediex of oligmacdmMe and almmada muctme wia be req~ed  te explala d~e molmdar tmls  d ~ese c m f f ~  ia 
charge. 
Introduction 
Most epithelial surfaces secrete mucus, which is a 
complex mixttne of mudn, lipid, and other solutes. 
After sec~tion, mucin forms a gel that lines and pro- 
tects the epithelium. The ptAncipal glycoprorein con- 
stituents of mucus are mucins, wifich are a family of 
high molecnia, weight, carbohydrate-rich glycoproteins 
that expres ~. an extraordinary degree of microhetero- 
geneity. Using histochemical and biochemical tech- 
niques, it has been shown that heterogeneity of mucin is 
seen as a function of its location within the gastroin- 
testinal tract [1-3], in certain disease stales [4-6], and 
with the processes of cellular differentiation and malig- 
nant transformation [7-11]. 
Cofr~dence: C.R- Boland, GI Section (lilD), VA Medical Center. 
2215 Fuller Road, Ann Arise, M1 ~8105, U.S.A. 
Using ion-exchange chromatography, Podi3bky and 
Isselhacher fraclionated colonic mucins into six 
species and demonstrated that one of these (designated 
species IV) was selectively reduced in the colonic matins 
of patients with nio:rative colitis [$]. F ~  it  
was demonstrated that th;¢ deficit pe~sted even in 
quie.~ent disease [12]- A simliar alteration has beelz 
found by the~e investigators in an ~nin~! model of 
colitis [13]. i t  is not yet known how this Izmchemical 
abnormality is related to the Ifistcchemical almonnali- 
ties that have been described in inflammatmy bowel 
disease [1,6,14-17]. 
Macin secreted by colon cancer is immunologically 
and biachemically different from that in the normal 
colon [7,8,10], but details regarding the molecular strne- 
tu~es of these different forms of mucin are not availa- 
ble. With the exception of the work done in ulcerative 
colitis [5,12], human colonic mucins in different disease 
states have not been analyzed using ion-exchange chro- 
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matogrephy. For the purposes of  this sludy, mut~ms 
from specime~ of normal and cancerous human co t  
onic tissues were analyzed by a slight modif'u:afion of 
the methods deuaibed by Podohty aad lssdbad~ 
[5,121. Samples of normal human culon, culon eaneer, 
and xenografts remained from cultured human colon 
cancer ~ lines were ~--,,~;,,~1 by extract i~ tissue 
gly¢~¢onjugales, radiohheling them, and fra¢lionatin s 
them ~ iou-exch~ge ~ y .  A sigaifm~ant 
aheratloa in the relative preporlions of thc scv~t mucin 
species was sma, with a shift towards less charged 
ameins in glye~oajnsate preparatious from enm=~ous 
tissues. The shift was more pronmmced in the uenograft 
spmmens. 
Malenlals aed Me ,ads  
Reagents 
Preparatioe and radiolabeling reagent& The following 
reagents were obtained from Sigma Chemical Company. 
(St- Louis, MO): sodium m-periodate (NalO,), galac- 
rose oxidase (EC 1.1.3.9). Tfis buffer, fibonud~tse A 
type IA (EC 3.1.27.5), donxyn'bonuclease ! (EC 3,1.21.1), 
p-men:eptuetha_-ol__ ~,: l i .m dodecyl sulfate (SDS), and 
Sepharose 4B. NaB3H, (specific activity 50-60 
mCi/mmol) was purchased from Amersham Corpor~ 
tina (Adingron H ~ L %  IL). Cesium ~ optical 
99.99~, purity, was ~ from Schwasz/ 
Mann (Ck'veland, OH). ~ i d e  and N, NLmethyl- 
cue ~ wgre purchased from Nalk~aJ Di- 
M m m ~  NJ. 
M ~  for standards in the carbohydrate 
analyAs we~ purchased from S/gma. Trifluoroacefie 
a~d (TFA) was purchased from Pierce (Rockford. IL). 
A 50~ (w/w) NaOH solution was purchased from 
Fischer Scientific (Livouh. MI). Sedium acetate was 
purchased from Sigma. The chromatographic sep- 
arations were pufonued on a Diouex BinLC gradient 
pump module with a model PAD 2 detector, and 
monosmxhari~ separation performed on a (4.6 × 250 
Elm) HPIC-AS6 anion-exchange column equipped will] 
an AG-6 guard column (Diouex, Smmyvak, CA). 
For ion-exchange chromatography, diethylamino- 
ethyl (DEAE) cellulose (free mesh) was purchased from 
Ti~ ~ex 
Fresh human tissues were obtained from the operat- 
ing room, and immediately prepared for study or frozen 
at --70°C until use~ Nine specimens of ~ y  
normal colonic epithelium were obtained from patients 
as ~ in Table L A total of seven specimens of 
freshly excised human colon cancer, and xenografts 
derived from two different cell lines were utilized. The 
tumor cell line LSI714T was obtained from the Ameri- 
can Type Culture Collectiou and was raised as a sub- 
TABLE I 
Human t~ues ured m sources of gO,.coconjugmes 
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T L ~  deslf~uttion Source of tLss~ 
NC (n = 7) Histolo~ly nolmxl colonic 
('normal-cLncer'. i.e. ¢phhelium from patieaats 
normal tissues from undergoing a resectioa foe 
cotons wilh carJcer) target: at lean 6 cm from 
any neoplastic lesion: all 
~ I g i ~  from the si~llOid COlOn 
NN (n E 2) l-Ii£to~etlly ~ colonic 
C nmmal.nomutl', i~. epithelium from patients 
nmma] tissues from ~ n g  resection for div~rtlculhis; 
~ c.okms) at least 6 cm from 
inflammation: both specimens 
from the sigmoid 
CA (~ = 7) Colonic adenocarc/noma; 
{ ~ )  CA-I, CA-5, CA-6. CA-12 
from the sigmoid colon: 
CA-2, CAll.  CA-14 from 
the asc~tdlng colon m" ce~t m 
I glT4T ( n = 4) ~bcutaneous xenograf! in 
(~g [blc) nude mice raised from huma~ 
cokmk cancer cell lin¢ LSI74T 
RW 29S2 (n =l) Subcutanccus x.cno~aft 
(c~ t~ne) from human colonic cam:~ 
ceU line RW 29~2 
cxttaneous, mucin-producing xenograft in the nude 
mouse as previously described [18_1. Xenografts from our 
different animals were utilized for re!~/lic~,*e studies. Cell 
line RW-2982 was obtained from Lmce Tiigx~tts0 M.D. 
(Providence, RI). This cell line grows as a muenid 
~ o n  in culture, and grows as bulky, noninvasive, 
muein-producing masses after the injection of ap- 
proximately 106 cells into the peritoneum of a nude 
mouse [19]. Subcutaneous tumors from these cells were 
obtained after 3-4 weeks of growth in the nude mouse. 
Extraction of glyc~onjugates from tissues 
Specimens of nooneoplastic colon were obtained by 
rinsing residual luminal debris from surgically excised 
colons and scraping the epithelial layer from the mus- 
cularis propria using the edge of a glass slide. Typically. 
2-10 g of tissue were obtained from a 5-10 cm segment 
of sigmoid colon. This material was immediately sus, 
petaled in 5 ml of phosphate-buffered saline (PBS). pH 
7.4, for each gram of tissue obtained. This gelatinous 
suspension was readily dispersed by 30 s of sonication. 
The ~ of cancer were immediately obtained 
from the operating room and sharply excised with a 
scalpel, trimming away adherent normal tissue (epi- 
tltelium, muscle, or fat) or necrotic debris. The tissue 
was minced with a scalpel, after which 5 ml of PBS, pH 
7.4, was added per g of tissue. The tissue was subjected 
to homogenization in a blender, followed by three 10-s 
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bursts of sonication using a Lab Line sonicator at a 
power setting of 90. 
The xenografts derived from the cell line LSI74T [18] 
and RW2982 [19] were sharply excised, minced, ho- 
mogeuized and sunicated in 5 vol. of PBS, in a manner 
similar to the other tissues. Each of these yielded a 
liquid suspension of ~sed tmm~ cells in a liquid 
medium. The suspensions were centrifuged at 105000 X 
g for 60 min at 4°C.  The supenmtant was applied to a 
5.0 × 100 cm column of Sepharose 4B equilibrated in 
PBS, pH 7.4, and developed at a rate of  1 ml/min,  with 
continuous monitoring of the effluent for protein using 
A ~ .  Fractions of 10 ml were colle~ed; the void volume 
peak was identified and pooled. This peak was dialyzed 
exhaustively against deionized water at 4°C, and 
lyophilizesl. This semi-purified mucin-containing pre- 
paration was utilized for radiolabeling and ior~x-  
change chromatographic analysis. 
The semi-purified mucm-Cou!aining sample was 
purified further ~ n g  equifilnimn density ultracentrifu- 
gation a~ording to the methods used by Podolsky and 
lsselbacher [5]. Briefly, a semi-purifi~ santple derived 
from the cell line LSI74T was subjected to n u c ~  
digestion (DNase and RNare) for 17 h at 3 7 ° C  in 10 ml 
PBS~ pH 7.4, containing 1 mM MgCI 2 and 0.02~ 
NAN3, centrifuged at 1 5 0 0 0 × g  for 30 min. and the 
supernalant was dialyzed against PBS. 12.8 g of CsCi 
were added and the sample volume adjusted to 24 ml, 
with a starting density of 1.39 g/ml .  The sample was 
centrifuged at 36000 tpm for 48 h in a Beckman L2-65B 
ultracentrifuge using an SW-41 rotor. Eight 1.5 nd 
fractions were pooled by aspiration and the specific 
gravity measured by weighing 1.00 ltd. As previously 
described, the fractions with dandties from 1.44 to 1_56 
g / m l  contain 'highly purified muein' [5], and there were 
used for radiolabeling and ion-exchange chromatogra- 
phy to compare with the semi-pmif~d or "mucin-con- 
raining" samples described above. 
Radiolabeling of glycoconjugater 
The lyophilized high molecular weight peak was 
weighed and 10 mg was dissolved in 2.0 ml of PEtS 
containing l mM NaIO4. This was incubated in the 
dark for 45 rain at 4°C ,  and dialyzed against PBS for 5 
h at 4oC. The sample was further oxidized with galac* 
rose oxidase (5 units) for 45 min at 37"C, and finally 
radiolabeled by reduction with 4 mCi of  NaB3H4 for 30 
min at 370C. The 3H-lebeied sample was then dialyzed 
ealtanstively against 0.01 M Tris, pH 8.0 at 4°C.  
Saponification of mucin using KOH 
in order to remove O-acetyl groups from sialic acids 
or colonic mucins [20], the 3H-laheled "reucin-contain- 
ins" preparations were subjected to mild base hydrolysis 
using 0.1 M KOH for 30 rain at 25°C as previously 
described by Gold et ul. 121l. To demonstrate that sialic 
acid or oligos~ceharides had n m  been renaov~d from the 
mu~n by these conditions, the preparation was sub- 
jetted to gel filtration through Sepharose 4B and the 
effluent monitored for ~ t y .  The ~ pre- 
paration was then ~ to hm-exchenge chro- 
matography as des~ibed above. 
Gel dectrophoreris of JH-labeled on~ns 
3H4aheled "mucin-cons~;~i~" samples were sub- 
~ t e d  to gel electrppborods to d e ~ n ~  the degee uf 
contamination by radiolahe~ lower ~ weigh~ 
non-mucin components. A 105 qnn s a n ~  was added 
to the sample buffer in the presence of ! - 5 ~  ~- 
mereaptoethanol final concentration, depending upon 
the volume of the sample, and 0.1~ sodium dedecyl 
sulfate. The eleclrophore~s was ran in a Tall Mighty 
Small elcetrophe~,~ apparatus (Hoefe~, San Ft 'anch~,  
CA) at a ccmstant ~ t  of  20 mA for 90-120 
The gels were fixed, dried on paper, and a u t o t a d ~  
grams w~e  produced r~ing standard x-ray film by 
deve~pmeut for 1-2 weeks. 
lon-exckange dwon~ography 
The radiolaheled samples were diluted to 2 0 - 1 0  ~ 
cpm/0.5 ml of  sample using 0.01 M Tris, pH 8.0. The 
sample was applied to a 0.9 × 30 cm column of  DEAE- 
cellulose equilibrated in 0.01 M Tris, pH 8.0. The col- 
umn was washed with buffer free of NaCI, and then 
e]uted with a discontinuous ascending NaCI g rad i~ t  
from 0.05 to 0.25 M, followed by a 5.0 M wash. The 
column was developed at 10 m l / h  and 2 nd fractions 
were collected. Seven peaks were duted over 4 h each 
(one at 0 mM NaC1, and one at each of the six different 
NaCI ennce~trations), consisting of 20 × 2 ml fractions, 
termed O-VI.  Aliquots of 100 pl were added to 10 tul 
of liquid scimillam (Safety Solve) and monitored for 
cpm. 
Meamrement of carbohydrate 
Separate samples were prepared for carbohydrate 
analysis in which the radiolaheling steps were omitted. 
For these experiments, a specimen of normal colon, cme 
of colonic cancer, and a specimen of the xenograft from 
LSI74T were selected on the basis of abundance of 
sample, from which glycoconjugates were extracted in 
PBS and subjected to gel filtration using Sepherose 4B. 
The void volume from each sample was pooled, dia- 
lyzed against distilled water, and concentrated by 
lyophiliT~tion for ion-exchange chromatography. 5 mg 
of each sample were dissolved in 0.01 M Tris buffer, 
applied to the DEAE-cellulose column, and the frac- 
tions collected as described above except that a 1.5 X 50 
cm column was used and eluted at 20 ml /h ,  and 4 ml 
fractions were collected and monitored for neutral 
hexose [22]. Each pooled peak (or "species') was di- 
alyzed against distilled water and concentrated by 
lyoptfilizatinn. Each of the sev~  ion-exchange chro- 
matography peaks was re~q~ended in 5 ml of water for 
carbohydrate analysis as fellow~ 
M~nesacchasides were measured by higl',-p~or- 
n~ ,ce  a . ion-exc tm~ d m ~ m o g r ~ y  and pulsed 
~ c  detection a~cording ~ the methed of 
Hardy et aL 12~]. Briefly, the samples were hydrolyzed 
in 2 M TFA at I~0°C for 5 h. The TFA was removed 
oring a nitro~m evaporator, and Lhe sampks wm'e retSs- 
solved in water. 
An alkluot of  50/d from each sample (approxima~y 
I pg mucin) was injected to the column and the analy~s 
of tmmmaccbafid~ was can'ied out at an i.~ctatic 
NaOH ormcentratim~ of 23 mM for 15 min, oring a flow 
rate of l ml /min at ambi~t  tempefalm~ The Dionex 
Eluant Degas Module was employed to s p m ~  and 
prer~w~e the duants with hefium. The mmum~- 
cbarides were det¢cud by pulsed amperomeu'ie detec- 
tion t~in$ a ~ l d  working ele~ode. A Ditmex Basic 
Port Column Delivery System was used to oblain ade- 
quate sensitivity. Sodium h3~koxi~ reagent (0-3 M) was 
mixed with the column effluent at a flow rate of I 
rid/rain. 
The fa~owing pulse pmentials and dmations were 
used for n ~ m a s a ~ u i d e  analysis: El =0.10 V(t ,  = 300 
m s ) ;  E 2 = 0 . 6 0  V (12 ~ 1 2 0  ms) ;  E 3 ~ - - 0 . 8 0  V ( t  3 ~ 300 
ms). The gesulting chromategraph~ data were in- 
tegrated u.~n 8 a Hewlett Packard 3392A integrator. 
For s~al~ add, the samples (20 pg m~cin) were first 
heated m 80°C for 1 h in 0.l M HzSO, t, evapmated 
under nitrogen and redissolved in 1 nd water. 50 pl 
aliqums were injected into the same colmon and .~a-lic 
acid was eluted with 100 mM NaOH conteining 150 
mM so~inm acelate. 
Ires,Its 
Preparat/on of muc/n-r/ch JH-/abe/~d samp/es 
The homoge~.atinn and senicatkm of tissu~ in PBS 
pecmitted the solubiSzatinn of mucosal gly~ennjugates, 
and ultrace.t~b"mgation removed ~ and mem- 
brane coutaminatinn. The ft~timmtion of the sample 
by coinmn chrol~tography resulted in the ~ of a 
high molecular w~ght mucin-con,~-~-~ peak |18]; a 
typical chromatogram is illustrated in F~g. I. The glyco- 
coajugates in this peak were ~ t r a t e d  and oxidized 
with Nal04 (which oxidizes siabc a~d residues), and 
gala~ese oxidase (which oxidizes gala~u~ and 
toramine), and then radiolaheled by reduction with 
NaB~H4 . 
Equilibriu~n densiO~ centrifugation of ra~olabeled mucins 
The radiolabeled mncin-fich specimens were ~ab- 
jec~ted to equilibrium density ultramntdfugatinn through 
a CsCI density gra~iant. The results demonstrated that 





F~g. I..~pharoie 4B c h x o m a ~  profil~ The t!ssue extracts were 
~b~led to ~ filtration ¢~tromatosmphy u~n~ ~a rose  4B, 
the ¢lnaat monitored far pr~eJa (A,zso). "Va tee peaks wtre developed 
a~d ft-~c~tions 21-28 e~re pooled as ~t ° nmcin-containin8° peak far the 
subsequent anal~s~. 
fractions (i.e. specific gravity ~ 1.38 g/ml) as demon- 
strated in Table 11. 
Pol~m~'ylamide gel elecffophoresis and auzoradiography 
To further assess the purity of the radiolabeled 
"mucin-containing" preparation, portions of samples de- 
rived from normal colonic mucin, colonic cargo, and 
LS174T were assessed by polyacry!amide gel electro- 
phoresls and autoradingraphy. Samples containing ap- 
proximately 105 cpm were applied to 10% and 4q~ 
polyacrylamide gels in the presence of both fl- 
me~captoet~nol and 0.1~ SDS. As indicated in Fig. 2, 
a broad band is seen at the top of the 10~ gel for 
normal colonic mucin (lane A)0 whereas the bands from 
caner-derived mucins (lanes B and C) enter the top of 
the gel  A small band is present in the dye front for 
both cancer-derived mucins. The radiolabeled bands 
from all three sources entered the 4~ gel (lanes D-F), 
TABLE II 
~ ull~.e~rifugatio~ of aH-labeled gl~coconjugaws 
A 3H-l~bc~.d sampled derived from the LSI74T xermgraft was sub- 
jetted m eap~h~riurn density ceatrifugalion as described in the text. 
Eishl 1.5 El fraY, arts were collected, the f4p~if~ gravity dele~'miRed 
by wei~he and volume, and the cpm delermlned in S0 It I allquols. 
Fra~a  Sp~:c~m cpm ~ of 
(glml) cpm 
i 1-27 140 3 
II 1.28 200 4 
HI 1.31 390 8 
IV 1.33 610 12 
V 1.36 806 16 
Vl 1.38 843 17 
Vii 1.47 1403 29 
VIII 1~6 510 10 
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Fig. 2. Autoradiogram of radiolabeled mucins after polyacrylamide 
gel electrophoresis. SH-labeled samples derived from normal colon. 
colon cancer, and LS174T xenograBs were used for polyacrylamide 
gel electrophoresis in tile presence of SDS and fl-mercaptoethanol. All 
specimens were obtained from the excluded volume after Sepharose 
4B column chromatography, but had not undergone equilibrium 
density eentrifugation, and were therefore representative of the ~ -  
pies subjected to ion-exchange chromatography. Lanes A. B, and C 
represent normal colonic mucin, colon cancer-associated mucin and 
mucin from LSI74T reslx~tively, electrophoresed on a 107o polyo 
acrylamide gel. Lanes D, E, and F represent the same three 
mucin-containing specimens aleetrophoresed on a 4% polyaeryl- 
amide g=!. 
a l t h o u g h  t h e  c a n c e r - d e r i v e d  b a n d s  ( l a n e s  E a n d  F )  
m i g r a t e d  f u r t h e r  t h a n  t h a t  f r o m  t n e  n o r m a l  c o l o n  ( l a n e  
D ) ,  
TABLE IV 
TABLE It[ 
Radiolabehng and culumn recouery efficienctes using NalO 4 and galac- 
rose oxidase 
Radiolabelthg dlid column recovery efficiencies using NalO 4 mad 
galaetose oxidase. Glycc, conjugate-coz'.zJ:--;:~ ¢~traet of the LSI74T 
xe~aografl wa~; prepared at 5 m g / m l  and 1.250 ml used for radizflabel- 
ing with galactose oxidase, NalO4. or both, as described in Materials 
and Methods. After removal of unreacted I~aB3H4 by dialy:is, the 
efficiency .3f labeling was calculated in terms of mg of glyeoeonjugate 
present per 2-10 ~ cpm. Column recovery represents the sum of all 
1factions recovered after application o1 2.106 cpm to the DEAE-c.ei- 
lulose col n K'ln, 
Oxidation method LSI74T glycoconjugate Column recovery 
(mg/2-106 cpm) cpm % 
Galactose oxidase 1.689 1A58.106 58 
NalO 4 0.601 1.416,106 71 
NalO~ and 
galactose oxidase 0.387 1 ~304,106 65 
Ion -exchange  chromatograph) '  
T h e  3 H - l a b e l e d  " m u c i n - c o n t a i n i n g "  s a m p l e s  w e r e  
f r a c t i o n a t e d  b y  i o n - e x c h a n g e  c h r o m a t o g r a p h y  u s i n g  
D E A E - c e l l u l o s e .  T h e  e l u t i o n  o f  s e v e n  m u c i n  p e a k s  ( o r  
' s p e c i e s ' )  [5]) p r o d u c e d  b y  t h e  x e n o g r a f t  d e r i v e d  f r o m  
L S 1 7 4 T  is d e m o n s t r a t e d  i n  F i g .  3,  i n  w h i c h  s p e c i e s  0 
r e p r e s e n t s  t h e  l a b e l e d  g l y c o c o n j u g a t e s  t h a t  p a s s  t h r o u g h  
t h e  c o l u m n ,  a n d  f r a c t i o n s  I V I  r e p r e s e n t  t h e  f r a c t i o n s  
s e q u e n t i a l l y  e l u t e d  w i t h  t h e  d i s c o n t i n u o u s ,  a s c e n d i n g  
N a C I  g r a d i e n t .  T h e  c o n t i n u o u s  l i n e  r e p r e s e n t s  c p m  
e l n t e d ;  t h e  d a s h e d  l ine  r e p r e s e n t s  t h e  p e r c e n t  o f  t h e  
t o t a l  e l u t e d  c p m  i n  e a c h  species .  A s  d e m o n s t r a t e d ,  
peak~  0 a n d  1 c o n t a i n  v e r y  l i t t l e  r a d i o a c t i v i t y ,  a n d  
m a j o r i t y  o f  c p m  w e r e  e l u t e d  in  p e a k s  I V  a n d  V .  
T o  assess  t h e  i n d i v i d u a l  ro l e s  o f  N a I O  a a n d  g a l a c t o s e  
o x i d a s e  in  t he  g e n e r a t i o n  o f  o x i d i z e d  s i t es  f o r  r e a c t i v e  
Ion.exchange ~hromatograpll~' of SH.labeled samples of non,~eopla~tie human colonic glyeo~o~gugates 
Percentage of cpm eluted in each DEAE ion-exchazlge chromatography species (0 VI) eluted using a discontinuous ascending NaCI gradient. NN 
refers to normal colonic epithelium derived from two patients with nonneoplastic disuse (diverticulilis). NC refers to normal colonic epithelium 
derived from seven palients who also had a colon c ~ c e r  il~ the resected specimen. 
Sample Glycoconjugate species (% of eluted cpm) 
0 I 11 Ill IV V VI 
NN-3 3.71 1.37 1.42 1.60 24.54 55.11 12.25 
NN-4 2.28 3.14 266 3 43 8.8t 68.05 11.63 
Mean 3.00 2.26 2,¢-~4 2.52 16.68 61,58 11.94 
NC-1 2.57 4.19 1.60 2 64 40.25 43.05 5.70 
NC-5 2.31 3.29 2.56 3A3 15.46 64.21 9.09 
NC-6 2.68 8.85 3.43 3.94 10.09 62,66 8,35 
NC-8 0.28 3.06 5.45 4.0l 24.00 50.75 12.45 
NC-9 1.16 5.60 3.03 2.46 25.75 54.37 7.63 
NC-12 0.79 1.47 1.19 2.04 37.80 49.14 7.57 
NC-I 3 0.31 1,15 1.72 3.57 32.72 49.65 10.88 
Meand:S.D. 1.44 d 1.06 3.94±2.65 2.71 ±1.45 3.11±0.76 26.58±11.21 53.40±7.64 8.80+2.25 
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Fig. 3. Ion-exchange chromatography profile after labeling with galactose oxidase and NaIO 4. The mucin-rich peak obtained from a xenograft of 
the human colon cancer ceil line LS174T was oxidized with both galactooe oxidase and N o l o  4, and radiolabeled by reduction with NaB3H4. The 
all-labeled glycoconjugates were applied to the DEAE-celiulose column, and eluted with a discontinuous ascending NaCI gradient (as indicated 
acro~ the top). The ¢pm are indicated by the solid line; the percent of total epm elutcd is in~atcated by the dotted line. 
r a d i o l a b e l i n g ,  a s a m p l e  o f  t h e  L S 1 7 4 T  x e n o g r a f t  p r e -  
p a r a t i o n  w a s  s e p a r a t e l y  o x i d i z e d  b y  e a c h  o f  t h e  t w o  
r e a g e n t s .  T a b l e  l I l  d e m o n s t r a t e s  t h e  r e l a t i v e  l a b e l i n g  
e f f i c i e n c y  o f  t h e  g a l a c t o s e  o x i d a s e  a n d  N a l O 4  m e t h o d s  
s e p a r a t e l y ,  a n d  t h e  r e su l t s  u s i n g  b o t h  t o g e t h e r .  A l s o  
d e p i c t e d  in  T a b l e  111 a r e  t h e  p e r c e n t  r e c o v e r i e s  f r o m  t h e  
'C.no 0 1 ' l ' l ' '  " 1 ' 1 '   0 .0SU I 0 .10M 0.1SM 0 . 2 0 U  0 ,25M 5 . 0 M "  N~CI 
7 0 0 0  70 
000O 00 
SOS0 so  
3 
3 o o o  3o 
2 o o o , , j , - * ' *  2 o 
1000 ~ 1(:1 
FrmcUon 10 20 30 40  50 60  70  00  90 100  110 120 
Fig. 4. Ion-exchange chromatography profile after oxidation with galaclooe oaidase only. This ion-exchange chroroatography profile was obtained 
by extracting glycoconjugates from a xenograft derived from the human colon cancer cell hne LSI74T. In this instance, the glycoconjugates wer~ 
oxidized with the galactose oxida$e, and subsequently radiolabe]ed by reduction with NaB3H4. The epm eluted are indicated by the solid line; tia¢ 
percent of total cpm elated in each species is indicated by the dotted line. Using galactose oxidase only, species [l and Il l  were preferentially 
labeled. 
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Fiyr 5. lon-excha~e c~Jrc~aogram ob~ined a f t~  o~ida~ica wlth NalO, c~y .  Th~s ¢~ramaml~m w a s / ~ h ~ d  L ~  ~ ~ 
us/rig a xe.jn~aft okayed from the h~mma corm c~c~-  ¢r.~ r~e l.SlT, f r  t b ~  were ~ ~L~g NsdO 4 foSowed by  ~ w~h Na ]~H, .  
Under ~ese coad~0~as, s p e c ~  IV , ~ s  p ~ e n e a ~  ~ 
DEAE-cellulose columns, us~g  each of the metlmds. 
Fig. 4 is a chromatogram demonstxating the cpm eluted 
in each ion-exchange species (continuous line), and the 
percent of  the total cpm recove~l  in each of the 
glycoconjugate sp~i~s (dashe~ lin~), a f t~  oxidizing with 
galactose oxidase alone. Fig. 5 is the con~spondbing 
clm~nato~ram for a sample oxidi~d by u~,ng only 
Na~O,. The galactose oxidsse prefere~tiany 
1! and IIl, whe~as NaI04 p r~f~ t i any  
labeled fraction IV. As indicated in Table ID. labe~ng 
TABLE V 
Dala axe percenlages of tcia] cpm eiuted in e a ~  ~ j u ~ t e  s p e ~  CA ind~ates a fresh suggic~y excised specl~nen ~ I~mmi ~ 
adenccarcinoma. LSI74T and RW-2982 are ~ xem~r~ts~ de~ 'ed from cu]tu~cl human colm~c ca~c~ c ~  
Sample G l y c o c o ~ u ~  ~ (~ ~ ~ cpm) 
0 ! 11 I n  IV V VI 
S u r ~  ~pectme~s 
CAol 2,90 3.76 2.85 15-21 47.32 23.02 4.94 
CA-2 1.19 2.15 2.05 4.16 46.56 38.84 51}5 
CA-5 5.39 5.55 5.73 5.63 19.41 46.33 11.96 
CA-6 $.15 8.07 6.67 6.35 15.55 48.11 10.10 
CA-11 0.64 1.60 2.74 7.43 52.66 26.97 7.96 
CA-12 252 3.66 4~M 7.94 28.44 39.59 13.71 
CA-14 i.00 2.67 7.26 15.80 54.95 12-69 5.63 
M ~ n  ± S.D. 2.684-1.98 3.92+2.24 4.49±2.07 8.93~4.66 3T.84 ± 16.35 33.65 :t: 13.10 8_48i3-53 
Xeuografts 
LSI74T-I 0.72 2.61 2.0"/ 9.10 40.44 36.83 8,23 
LSI74T-2 3.91 2.87 3.2"/ 7-51 43-53 34.27 4.64 
LSI74T-3 3.26 4.49 2.88 7.22 40.03 35.99 6_13 
LS174T-4 0.73 1.99 8.23 15.31 43.78 23.52 6.~4 
Mt:~n ~- S.D. Lg0~ 1.36 33.5 + 1.15 4.11 :~2.75 9'79+3_77 41.95:1:1.98 32~65 - t -6 .18  6.36-t-L47 
RW2982 0.36 2.10 8.04 18.58 57.47 8.87 4-58 
TABLE Vi 
V~cs mrc m~m±S.D, of the pcs~¢ffi~ages ~ ~ H ~  ~ocon- 
t ~ s  with c a ~ ,  CA, sm~c~-y ~ Immm ce~m ~amc~ sped- 
m~s; LS, su~gutu~mm ~mo~ from 1.S174Tce~; g w .  s ~ a -  
C~Jycoco~ P e m ~ c ~ n e ~ a m g k ~ s p e c ~  P ~ t ~  
~ Oa~l )  aH m~-mab ~ c a ~  
t'mm + ~ ' )  (CA+LS+RW) 
l (O.05M) 3,57~: 2.45 3~5± I.&q a~. 
H! (0.2.~M) 2 . ~ ±  0 . ~  10.ff2± ,&Sl P < 0 . ~  
V (0.25M) 55.224- ~ 31.25±12.40 P<0~00~ 
V1 {~M) 9 J l ±  2.39 7A~± 3.04 ms. 
with NaIO 4 alane resulted in approv.imately 2.8-times 
the specific activity actu~-ved with ~ oxidase 
alone. 
Glycoconjugates were ~ac~ted from the ~ san~ 
p~s or nouneoplas~ human o~n, tndic4abek~ and 
subjectnd to i o n - e x ~  c ~ r , ~ 0 ~ p h y  ~s deu:n'bed 
above. Thc percents of cpm cluting in c~ch of the seven 
species (O-VI) are deputed in T a l ~  IV. "I'h~ ffurs| two 
s p ~ - , - ~  can~ from padants who had andetgan~ re- 
s ~ m  of t l~ signmid co~n for dive~licv~tis (NN..~ee 
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Table I). The last seven specimens were histologically 
normal co~on~ epithelium from patients who had ou- 
dergo~e a resection for cancer (NC, see Table 1). In 
both groups, nearly 80~ of the cpm duted in peaks IV 
and V, and mo~© than half of the counts were found in 
peak V. The samphes derived from patients who did not 
have cancer elsewhere in the colon had the largest 
percentage of cpm in peak V (mean 629~), however them 
were only two samples from this group. 
The data derived from the samples of colon c~nc~'r 
are depicted in Table V. The fi~st seven samples were 
derived from fresh surgical specimens of human colon 
cancer, and in four instances represent paired specinums 
that correspond to samples of nonneoplastic tissue (see 
NC-I, 5, 6, and 12 in Table IV). The cpm eluded in 
species V from the seven specimens of cancer are sig- 
nificanlly less than the corresponding 81ycoconjug~ 
spc¢~ found in the nine specimens of uonneoplastic 
(P  <0.005). The loss of counts in species V from 
the seven s p i n . a s  of colon cancer is reflected by a 
~olrespondin~ significant increase of cpm in species I l l  
( P  < 0.02), and nonsignificant iv~reases in species II 
and IV (Pffi0.06 and Pffi0.12, rcsp~tively). This ob- 
servatian, specifically a shift towards less-charged glyco- 
¢onjuf~ates species, was also sccn and was morc marked 
in the samples d~rivcd from the two xemografls, LS174T 
and RW2982 (Table V). When the combined data for 
all of the normal ~ specimans (NC and NN) were 
compared with the combined cancer sp~cime~ (CA, 
1LS174T and RW2982), highly sisnificant differences 
were seen for species I1 (P <0.028), !I1 (P <0.0(05), 
IV ( P  < 0.008)  and  V ( P  < 0.0005), with a shift away 
TABLE Vfl 
C~,bohyd~tes ame expressed a,~ pmo] in I m~l of f~  fra~,i~ e~ted ~nmg ~a-e~te,~ ch~malogl~y u~iog i~on~beled  glycoco~jugates. 
~ , ~ s  ~ s e p ~  by ~ ~ (from Tab~ IV). CLIO, carbohydrate: Fuc, fucme; GAIN. 
~ s ~ e s  
o I I! HI IV v vl 
CHO 
Fe~ 0.670 (9~)  ~Url2 (16.0~L) 3J37 (16J~) 9.3~ (173~) 12-~61 (15.6%) 65-~49 (10.8~) 2&5~7 (IX6~) 
GaIN 2.488 (33..5*~) !.855 (|4.7~) 5.7A9 (.~.2~ 8.869 (16.SYn) 9.231 (I13~) 115.566 (19.0~) 22.031 (12.0~) 
GJcN 2.4~ O3.5~} 4.525 (35.9~o) 8.145 (37.6~) 18.145 (3~.7~) 23.620 (29J~,} 136.3~5 (22.d~) 50.090 (27.3e~) 
Gad I.T/S (23.9~) 4.222 (33..51) 4.Tn (21A~) i 2.'7-/80.3.7~) 19.61 ! (23.3~,) 143.278 (23.59~) 56._q00 (30.8~) 
a~d ~ n.d. e~. 4.693 ($.7%) 15_q66 (19.3%) !,1&738 (24.,!%) 26.214 (14.3Yo) 
Te4ad 
@tool 7A2,4 (100~) 12.614 {100~) 2L65] (|00¢~) 53~14 (100~) S0~$9 (100~) 609.466 (IO0~) 183.377 (100~) 
~toud 
CHO 0-8 1-t 2.2 5.6 8,3 62.9 18.9 
cp~ 1.4 3.9 2.7 3.1 ~i.6 53.4 8.8 
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TABLE VIII 
C m ~ g e  ~ - c ~ c  c a ~ c ~ - a s s o c k n ~ g ~ c ~ e s  
C ~ b ~ y d r a m  me expressed ~ ~meH= i m~ ef ~*e f.,rac~a e~u:d ~ ie~u.examu~ ~ y  ustug ~ ~ 
M~ar perce~ges for ~ i~ak xre ~ ia I ~ r e ~ e ~  afu= ea~  va~e in ~ ~ ~ C ~  ~ ~ ~ ~ ~ ~ m ~ 
giyeeco~juga~s we~ separated by iea-exc~%u~e d~m~r, egr'ap~y (from T ~ l e  V). CLIO. ~ , d ~ I ~ = e : :  Fue.~ fia~o~g GAIN, 
G I ~ o : ~  species 
0 I II  111 IV V VJ 
CHO 
Fu~ 9.3~ (1&8%) 4-~12 (14.65) 13AI~ C20.2~) 29.Y~ {15.0~) 237.622 (16.7~) 97.012 f17.~)  ~-1~4 ( IZI~)  
GaIN 12J~J6 (27.4~) 9,774 (31.6~) 21.222 (~0~i~) 3L403 (16A~E) 175.792 (i'~ 4~) 11"; 127 (19.9~) 4L~67 (1~-~) 
Glen 10.99~ (23.4~) ! 1.1T6 (~6.2~) 23.439 (35.,;~) 59.457 (~0.4~) 309.095 (2L8~) 119.910 OI.3~ ) 7&!9~ (29A]g) 
Ga] 13.833 (29.4%) $.4~ (17A~) &222 (IZ49) . ~ 1 1  ( ~ $ )  462.222 (3Z65) I~t.TP8 C~&6~) 91.444(34.3%) 
acid n.d. a.d. n.d. 15_599 (8.0~) 235.146 (16,6~) 73,042 f13 .~)  23.333 (8J~)  
Total 
pmol 47.053(100%) 30.906 (lO0~) 66.2~8 (1Q)~) 195.3~9 (IGOr) 1419~rl {IU0~) 562~9  fl~O~) 2~36~ (100~) 
ClIO 1.8 1.2 2.6 7-5 ~ 2].7 10.3 
% total 
cpm 2.7 3.9 4.5 &9 37.8 33.7 
f r o m  peak V toward  less charged  glycoconjugatcs  e l m -  those  ob ta ined  us ing  semi-pur i f icd  m u c i n - c o m a ; n l n g  
ing  in  ead ie r  f rac t ions  ( I I - I V )  for  the  spec imens  der ived  samples  (da ta  n o t  p rcsemcd) .  
f r o m  co lon  cance~s (Tab le  VI) .  
Ion-exchange  ch roma tog raphy  w as  pe r fo rmed  o n  M ~ o ~ . c ~  a n a ~ s / s  
' h i g h l y  pur i f i ed  mucin" ob laJned  f ro m the  L S i 7 4 T  cel l  The results o f  analys is  o f  ~ (spec/fi-  
l i ne  as d e s ~ l ~ l  i n  Ma le~a ls  and Methods (Lc., tha t  t a l l y ,  ~ ~ g l u c o s a m J ~  ga lac t~ ,amim~ a ~ l  
subjected to  add i t iona l  nuclease  d iges t ion  a n d  ul- ~ acid) for each of the sevea ion-exchange peaks ZLrC 
t r acenu i fuga t ion  t h rough  a C s ~  g rad ien t  p r i o r  to  label -  l is ted i n  T ab l e  V I I  ( fo r  n o r m a l  co lonic  munro) ,  T a b l e  
ing).  T h e  ion-exchange e lu t iou  prof i les  were ident ical  to  V I I I  ( for  co lon  cancer-associa ted mucin) ,  a n d  T a b l e  I X  
TABLE IX 
CaH~h~lraa~ a~ e x ~ - = d  a~ ~m~ i~ I mJ ~ ~ f r ~ f i ~  e~u~l dux i~ ~ dunmmaxo~ap~ us i~ ~ ~ 
Molar pe~eata~e~ fe¢ each peak are 8ivm i~ parem~ses afar em:h valee i~ p ~  ~ ~ ~ ~ ~ ~ ~ ~ m ~ 
specles compare~ to the smm of c:mbehydrate f~- aa se-.,m specxs. ~ toua cpm ~ ~ ~ ~ d ~ ~ m ~ ~ ~ 
radiolabeled ~ly~c~aju~a~s v~re s ~  by i~-eze.h~rSe ~ (from Tal~e V)_ CHO, c ~  Fu~ ~ C~m]N, 
galactoem.mi~; G~cN, glucosae~ne; Gal, ~a]ac~ose; Ld., eo~e d~ected. 
G l ~ j u e a t e  We,~s 
0 l 1~ I l l  IV V Vl 
CHO 
Fuc 1.037 (11.7~) 2.744 (|6.4%) 6.159 (14-~)  21.280 (13.8~) 7&415 (161~) 45A83 (8 .~ )  35.122 (13-~)  
GaIN 0.588 (6o6~.) 2.443 (14.6~) 10.860 (25.2~,) 26.335 (17.~m) T2-036 (14.9~o) T2.579 (14.3~,) 30..,~0 (11.9~) 
Glen 4.163 (47.0~) 9.412 (56.3~,) 18.109 (42.2~) 54.0"12 (3~.0~,) 129.593 (~.7~) 95A30 (18.8~) 67~14 (7.5.8~) 
Gal 3.056 (M.6~) 2.111 (12.6~) 6.389 (l&8~) 43...~0 (28.1 ~)  135.056 (27.9~) 23~L889 (26.5~) 118.056 (45..5S) 
sialic 
acid n.d. nJ:L !~53 (3.6~) 9-515 (6,.2~) 69.385 (14.3~) 58.414 (I LSS) &ra06 (3..3~) 
Total 
pmol 8.844 (100~) 16.710 (100~) 43.151 (100~) IM.702 (i00~) 484.485 (100~) 507.495(100%) 259~0 (100~} 
% total 
CHO 0.6 I.I 2.9 10.5 32.8 34.4 17.6 
total 
cpm 1.9 3.3 4.1 '9.8 43.0 32.7 6.4 
TABLE X 
The ~ a~d o ~ m  ter ~ ~t~ies ia the ~ mab'z~ ia 
T ~  VII-IX ~e ~ ia eme~ ira" pmel of ~be mm of the 




3 8"/ 80 62 
4 193 166 143 
5 244 130 1 ~  
6 143 n 33 
(for cancer-associated mucin derived from the tomor 
ceil line LSI74T). It  is appanmt that each i o ~  
species conlnins aU five sugar moieties fotmd in mucins. 
Table X ~ the ~ acid coment r.x~c:~mi as a 
~ of tbo total ~ t e  coatent of each species 
for these samples, i t  appem3 from Table X that dif- 
ferencas in slalk acid coment do not entirely account 
for retention em the DEAE-ceihdose_ 
.~pomf~a:/m of O-acetytated sia~c 
Radiolabekd mucin samples from the nmmal colon 
ami x e n o g ~ t  of  LSI74T cells were ~ as de- 
sefibed, and nentsalized with 0.1 M HCL A portion of  
each ~ was mbjected to ge~ filtrmion through 
Sepharose 4B, and all of  the r~ioactivity ehated as a 
sin~e high molecular w e ~ t  peak, ind~, i .~  that no 
degradafiou of  radiolabekd groups had orcomxL The 
~ponified samp~ wete c~mmognphed ou DEA~- 
ceHulme columns as desm'bed above. The sapanified 
samples dufed identicatly to the untreated samples (dam 
not shown), ~ that differences in O-acetylatlun 
did not account for the differential retantion on the 
iowexc~umge column see between the mmual and 
c a n c e r - ~  
l~scmdun 
In the experiments presented, glycoconjugates wese 
tritinm~labded ~ a ~ of the techniques 
develol~l by Podohky and ~ e l b a ~  [12|, lint the iou- 
exchange chromatography profiles we produced with 
extracls from the normal colons are different from those 
obtained by these investigate~. Specifically, we seb- 
jected our tissue extracts to Sepharose 413 chromatog- 
raphy before the radinhd~nng step, which cou~ change 
both the labeling efficiem:ies of the mucins in the pre- 
paration and the relative recoveries of  rad io labe~ 
mucins. Moreover, Podolsky and lsselhacher initially 
equilibrated their DEAE-ceUulose in 1.0 M Tris buffet 
prior to equih'bralinn in 0.0l M Tds for the sample 
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separations (personal communication). Although we ob- 
served no change in the elution prof'des throughout the 
several dozen chromatographic mas necessary for this 
work that might susgest slow ~qnilibration of  the col- 
anm with inereasing amounts of Tris base, this dif- 
f ~  cannot bc excluded as an explanation of our 
results. However, a small number of samples has been 
chromatol~phed in our laboratory after equilibration 
of the ion-exchange resin in L0 M Tris, and the 3H- 
labeled nmcb~ w e e  found to ehite at lower ionic 
strength {data not presented). As a result, the altered 
repr~co:ation of the charge in the seven mucin species 
seea in caneer-msociated 81ycoconjugates may not be 
strictly ,~uparable to those repotted using extracts 
from samples of inflammatmy bowel disease [5,12]. 
Because of the uniform reproducibility of the data 
with this method in our laboratory, we examined the 
individual contributions of NalO, and gelactose oxidase 
in the labeling of colonic glyceconjugetes to explain the 
disctepanciss between our results and those previously 
reported. These experiments demonstrated different 
oxidiTJm 3 efflciencies with the two reagents; reduction 
with NaB3H4 ~esulted in almost 3-fold greatet specific 
activity after oxidmlon with Nai04 alone compared 
with that produced after oxidation with gala~ose 
oxidase alone (Table Ill). Recovery of 3H-labeled glyco- 
conjugates f,-~m the DEAE-cellulose columns was simi- 
lar with both methods. Also, galactme oxidase (which 
results in the labelin s of galactcne and N-acetylgalac- 
tmamine) tended to label glycneonjugate species I! and 
Il l  more prominently (Fig. 4), whereas NalO 4 (which 
of i ,K.~ ~ acid residues, and therefore would be 
expected to label the m o ~  acidic species) labeled species 
IV and V best. Since the effioie~y of labeling with 
g ~ t n s e  oxidase was considerably less than that 
with NalO4, it would appear that differences 
in the galactose oxidase activity could account for dif- 
ferel~es in the glycoconjugate species labeled from one 
laboratory to another. Alternatively, a diffe t~ce in the 
source of the ion-exchange resin could produce different 
dutiou profiles. The principal difference between this 
work and that of Podolsky and Isselbacher is that the 
latter laboratmy had a larger percentage of the tdtiom. 
labeled species in f~..ctlons l - I l l .  
Al t lmu~ not strictly comparable, the i~-exchange 
chromatography profde reported by LaMont and 
Ventola [24] on nonsadiolabeled rat colonic mucim 
demonstrated a predominant peak in mucin species IV 
when assayed for A280 end neutral hexme. Kim and 
Horowitz studied canine gastric mucins by ion-ex- 
change chromatography in 1971 |25J, again monitoring 
the aluant for .4~o and neutral hexose. The principal 
during fractions were found at 0.2-0.3 M NaCI (corre- 
sponding to species IV and V using our gradient). 
Although similar to our results, comparisons of this sort 
are of l imi~l  value since they utilize different sources 
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of mucin (both with respect m ~ and orsan), and 
the e]utcd fractions ~ moni tm~ for protein (A~o) 
and neutral hexose, which detects different compo~ats  
of the mucosal glyenennjugates than that achieved by 
the use of the radiolaheling t e c ~  
In spite of the above-stated ~n~lerat ions,  there 
were highly ¢igniflcant differences in the inn-exchange 
chromatogra~y ~nti0n profiles between g~yceam- 
ju~ates obtained from nmmal human colonic epithdium 
and colon cancers. The most ~ t  d i f fevm~ is 
that a charged species (V) accmmted ft~r the majodty of  
the tfitium-~aheled glycoconjugates in the normal 
whereas the profiles obtained from cancer specime~ 
had a significant deficit of species V and corresponding 
i n ~ e a ~  in the k s s - c h a r ~  s p e c ~  
It  was of  interest to note that the spec;n~*ng derived 
from human colons without cancer (NN) had the grea- 
test percemage of  tritium-labeled glyu~on~Jgates in 
species V~ althoush the number of  these samples is 
small aud it cannot be asce~tined whether this is 
sisnifgantiy different from that seen in the nonneoplas- 
tic macosal specimens obtained from colons that were 
resected for cancer (NC). It has been t ~ r t e d  by some 
investigators that glyenennjugate h i s t o c h e n ~  is 
abnormal throughout the entire colon in the setting of  
colon cancer [26]° It is possible that "nmmai-normal' 
colons are distinct from "nonual*cam:er" colons, but the 
differences we have reported between NN and NC 
specimens are difficult to intexpt~t at this time. 
Very significant changes were seea in the enaner 
specinlells With Coordinant deffa:iL5 in s p e ~ s  V 
increases in species 11. IIL o.~d IV. These changes were 
even more p ~  in the suheu,m~mts xenografts 
derived from the mucin-pmduc~ng co~n cancer cell line 
LSI74T, and the shift to more neutral species was 
exaggerated further in the xenogrMts d~'ived from the 
human colon cancer cell line RW?'?82. This cell line 
demonstrates unusual growth characteristics in suspen* 
sion culture and is a prodigious producer of  mucin [19], 
but the biolosical significance of this shift towards 
less-charged gl3n~onjugates t ~ i : ~  to he explo~d. 
The biochemical basis of the prodm:tion of less- 
charged glyenen~jugates t5 tmdenr at this time. The 
method we employed for glycoconjugate preparation 
preferentially recovered mucin, h c ~ e r  the 'mucin- 
containing' fraction obtained by Sepharose 4B column 
chromatography may also contain small amounts of 
contaminating proteins, lipids and other glycoproteins. 
The use of the radiolabeling teclmiques increases the 
ability to detect mucin Klycoproteins by speciflcally 
labeling those re ,dues  abundantly represented in mucin 
oligo~cchaddes [27,28l. The analysis of the "mucin- 
containing" preparation by CsCI density gradient ultra- 
centrifugation (Table II) indicates that an i n s i ~ z c a n t  
proportion of the cpm is present in either 5pids or 
proteins (which would band in low-density fractions). 
The antoradin~ams of  the ~ ge~ fFi& 2) 
also indiente that the ~ ~ i e ~  are breed, 
high molecular weisht bands characteds~ of macin~ 
Of  interest, the autmadiogram in l~f~ 2 indicates that 
there is a difference hetween the ~ weights of 
reduced mucins from normal cokes  and enn~fs,  which 
h ~  never previously been ~ Moreover, the 
~-~abobyd~te contents of the eluted ~ (Tables 
Vl l -X)  a~-~ ~ only of ~ 129]. Thin, the 
p ~ a ]  glycomnjugates that n~t~,., up the elmed 
speries are mecins. 
The mechanisms that account for c h a ~  in the 
mok~lar charge of mucins are ~ y  under- 
stood, however there me at least two peem'b~ exp]mm- 
tinns. Fret ,  the symhesis of  a ~mvel a p o ~ o ~ n  less 
richly represented with basic nes&lues in canc~-as~c~ 
ated mucins oould change the ~ l i c  strength with w h ~  
a glyo0ennjugate species would be ¢tuted from DEAE- 
celinlos~ However, mucin glycoprotelm from nmmal 
tissues tend to be chmsdy glycmylated, and enkmic 
mucins have relatively few nonglycmylated, "exposed" 
p~tions of protein available f ~  intenemiou with the 
ion-exchange resin [291. The apparent d~ffermcm in 
~ w~ght between these mucins rahes the p o s ~  
bi~ty of the synthesis of a unique apomucin pro~in by 
calgerom tissues. How~*ver. since no mucin apeprmem 
has ever been pmified or  sequenced, and no apmnucin 
gene has yet heen clone0, it is premature to speenlate 
further on this h3qpothe~s. 
Secondly, a change in o l i ~  slmonwes enukl 
account for diffeter~es in molecular c h a r ~  and result 
in differem ion-exchange c h r o m ~ y  IWOfi]h~ The 
expression of the 1 1 u m ~ - F r i e d e a r e i ~  an~gen on 
c a n c e r - ~ t e d  nmcins [8-10] and Ihe absence d th~ 
~dc tu re  in the normal colon [30,31] has led to the 
hypothesis that cancer-associnted n x u ~  are ahenantly 
glycosylated, and perhaps incom~-tely glycosylatt-.rl 
compaxed to mucins from the normal t ~ n  [8]. This 
hypothesis has been supported by pr~imin~ry data from 
our laberatory using beta-elhninmed colonic mucins, 
which suggest that concer-associated r m ~  have 
shorter oligmacchadde chains compared to their normal 
COUnterparts [32]. 
A~lys i s  of monosaccharide content in each fraction 
of the three nonradiolabeled samples revealed that each 
sample contained the five sugar residues found in 
mucin-type glycoennjugates, and the carbohydrate con* 
tent of each fraction was proportional to tim qxn  e~uted 
in the earlier experiments~ Only sialic acid content w ~  
differentially expressed, tending to be bellow the limits 
of detection in species 0- l l I ,  and being highest in 
fractions IV and V. A trend towards ~ rdafive 
acid content in the cancer specinmm is evident when 
expressed in terms of the total carbohydrate coatenL 
However, as demonstrated in Table X, ~ acid con- 
tent alone probably does not account for the separation 
of the seven pe~s~ F m ~  ~e removal o~ 0 - ~  
g r o e p s  f ro m s i a ~  a d d s  p roduced  n o  d m ~ e  i n  t e r m -  
l i o n  c ~  D E A E . c ~ u l o ~  A m o ~  ~ p l e s e  analysts  o f  
residues dcrlved from cancer-msociau~l mucins, 
~ t i o n  of the apomucins from mmmd and 
ma]~nam ~ma~,, aad an undemandin~ c~ the dm~-di- 
mensional stracture of  m u c ~  Frmn the data dmt are 
c l m e n l l y  avai lable ,  it  i s  on ly  ipee~'ble to  say  tha t  lhe  
m u ~ n s  f rom co lon  caace r  e ~ p r e ~  a l  leas l  s o me  differ-  
m t  c a r b o h y d ~ e  s e q a m c e s  [8], are  a m ~ a i c a ~  d ~  
t inct  f rom no rma l  ~ muc /ns  [7,33], con ta in  fewer 
O-acetyl  g r m ~  o n  ~ acids  121}, a n d  c u r  work  
~ tha t  r ~ i o l a b e ~  g l y m c e a j e g a t e s  der ived  
f r o m  c c ~ n  ~ have  a d i f f e~mt  ~elafive c h a r ~  a n d  
m o l e m l a r  v , ~ , h t  t han  d o  the i r  n m m a l  m u n ~ p a r ~  
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